Other Therapeutic Substance device includes:

  • Idarucizumab, Pradaxa(R)(dabigatran) reversal agent
  • Praxbind(R) (idarucizumab), Pradaxa(R)(dabigatran) reversal agent
MS-DRG - Medicare Severity-Diagnosis Related Group
  • MDC 04 Diseases & Disorders of the Respiratory System
    Other Respiratory System O.R. Procedures
    • DRG 166 - OTHER RESPIRATORY SYSTEM O.R. PROCEDURES WITH MCC
    • DRG 167 - OTHER RESPIRATORY SYSTEM O.R. PROCEDURES WITH CC
    • DRG 168 - OTHER RESPIRATORY SYSTEM O.R. PROCEDURES WITHOUT CC/MCC
  • MDC 05 Diseases & Disorders of the Circulatory System
    Other Circulatory O.R. Procedures
    • DRG 264 - OTHER CIRCULATORY SYSTEM O.R. PROCEDURES
  • MDC 99 Other
    Non-extensive Procedure Unrelated to Principal Diagnosis
    • DRG 987 - NON-EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS WITH MCC
    • DRG 988 - NON-EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS WITH CC
    • DRG 989 - NON-EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS WITHOUT CC/MCC

ICD-10-PCS code structure for 3E0L4GCSee Table View

1: Section 3 Administration
2: Body System E Physiological Systems and Anatomical Regions
3: Root Operation 0 Introduction
4: Body Part L Pleural Cavity
5: Approach 4 Percutaneous Endoscopic
6: Device G Other Therapeutic Substance
7: Qualifier C Other Substance

See also

  • The ICD-10-PCS Index of common procedure terms.
  • Administration terms in the ICD-10-PCS Definitions table. These definitions may also provide additional explanation and/or examples within this section.
  • The ICD-10-PCS Device Aggregation Table containing entries that correlate a specific ICD-10-PCS device value with a general device value to be used in tables containing only general device values.